JILL NEWTON: Open Payments
NPI 1013353846 · ELIZABETHTON, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,036 in 55 payments from 10 companies in 2025. Trend: 2023 $411 · 2024 $638 · 2025 $1,036
Food & beverage: $1,036
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 17 | $309 |
| Neurocrine BioSciences, Inc. | 10 | $179 |
| Janssen Pharmaceuticals, Inc | 9 | $156 |
| Lundbeck LLC | 5 | $101 |
| Teva Pharmaceuticals USA, Inc. | 4 | $87 |
| Vanda Pharmaceuticals Inc. | 3 | $68 |
| Axsome Therapeutics, Inc. | 3 | $61 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
| E.R. Squibb & Sons, L.L.C. | 1 | $25 |
| ABBVIE INC. | 1 | $15 |
Products named: ARISTADA, INGREZZA, INVEGA SUSTENNA, ABILIFY MAINTENA, HETLIOZ, Auvelity, AUSTEDO XR, UZEDY.
Industry payments across TN — which companies pay providers there.
